Phebra is deeply saddened to announce the passing of its Founder and former Chief Executive Officer, Dr Mal Eutick OAM, who died in Sydney on Sunday 3 August. Phebra staff extend our heart-felt condolences to Dr Eutick’s family and friends during this difficult time.
Dr Eutick was a leading figure in the Australian pharmaceutical industry, establishing Phebra’s manufacturing capability in March 1998, as a small-scale production plant in Sydney which specialised in hospital products, gradually developing and acquiring a growing range of critical care medicines to service Australian hospitals.
Fast forward to today, and Phebra is a successful Australian-owned manufacturer, a trusted and innovative supplier of over 60 critical care medicines in Australia, New Zealand, UK, Canada, the Middle East, the Americas and in South-East Asia. Phebra is, a testament to the vision Dr Eutick had for Phebra and the Australian pharmaceutical industry.
Paying tribute to Dr Eutick today, Phebra Chairman, long-time friend and co-Founder, Anthony Cordato, said Dr Eutick’s unwavering dedication and commitment to improving patient outcomes through cutting-edge research and innovative product development (R&D) had been at the heart of Phebra’s success.
“Everyone at Phebra is deeply saddened by Mal’s death. It’s a tremendous loss for our Company and the entire Australian pharma industry. Mal’s vision and leadership has been instrumental in shaping Phebra’s success as a leader in the field of critical care medicines,” Mr. Cordato said.
“Mal was always keenly interested in new pharmaceuticals. A prime example is the development of an arsenic-based cancer product called Phenasen ® for the treatment of acute promyelocytic leukemia. That was Mal, focused on developing drugs which have improved the lives of so many people across the community.”
In 1995 Dr Eutick was awarded the medal of the Order of Australia (OAM) for service to biotechnology.
He was also a passionate patron of the fine arts, establishing and sponsoring the Eutick Memorial Still Life Award (EMSLA) in 2006, in regional centres across NSW. He was Vice-President of the Australian Museum for eight years.
Vale.
About us:
About Phebra
Phebra is an Australian based specialty pharmaceutical company which develops, manufactures and markets critical medicines in Australia and across the world.
At Phebra, we create critical medicines that save and improve lives.
Contact details:
Richard Lenarduzzi
+61 411 254 390
